NYNRIN, with its multifaceted roles in endoribonuclease activity and mRNA binding, represents a fascinating target for chemical intervention. NYNRIN inhibitors encompass specialized chemical entities that can disrupt NYNRIN's functions either directly or indirectly. Among these, chemicals like 8-Azaguanine and 5-Fluorouracil exhibit indirect effects by targeting nucleotide synthesis pathways. These perturbations in nucleotide metabolism can lead to the generation of aberrant RNA molecules that may no longer serve as suitable substrates for NYNRIN's endoribonuclease function, thus impacting its role in RNA processing.
Moreover, compounds like Ribavirin and Neomycin exert direct influences on RNA structures and metabolism, altering the accessibility of mRNA for NYNRIN to act upon. Spliceostatin A and Ellipticine offer unique modes of inhibition, affecting splicing and nucleic acid structures, respectively. These mechanisms can limit NYNRIN's opportunities to fulfill its predicted roles in RNA processing, adding a layer of complexity to the array of inhibitors. Therefore, this curated list of chemicals represents a robust strategy for NYNRIN inhibition, irrespective of its subcellular localization, whether it operates within the nucleus, cytoplasmic ribonucleoprotein granules, or membrane-bound configurations. The nuanced interplay between these inhibitors and NYNRIN's multifunctional role in RNA metabolism underscores the for precise chemical control over this intriguing molecular entity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Azaguanine | 134-58-7 | sc-207194 sc-207194A | 1 g 5 g | $84.00 $212.00 | 1 | |
Inhibits purine synthesis, disrupting RNA processing and therefore indirectly limiting NYNRIN activity if involved in RNA modifications. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Inhibits thymidylate synthase, which can cause RNA misprocessing and indirectly affect NYNRIN if it acts on malformed RNA sequences. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
A purine analogue that inhibits inosine monophosphate dehydrogenase, affecting RNA metabolism and thus potentially NYNRIN's role in mRNA processing. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Binds to RNA structures and inhibits translation. Could interfere with NYNRIN's mRNA binding activity. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Affects mRNA splicing, which can affect NYNRIN if it's involved in mRNA processing steps that are splice-dependent. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Intercalates into DNA and RNA, affecting transcription and translation, which can indirectly impact NYNRIN's RNA-related functions. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Aminopeptidase inhibitor that can affect peptide processing, which can indirectly inhibit NYNRIN if it interacts with specific peptides for functionality. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, affecting transcription and potentially limiting the substrate availability for NYNRIN's RNA-related activity. | ||||||